SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
ImmunoScape presented compelling new preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Demand for coins, bars continue in main markets* Gold to range from $1,360-$1,405 -technicalsID:nL3N0D6538* Coming Up: U.S.
Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...
Researchers have introduced a platform to analyze heart fibroblast behavior, revealing pathways involved in fibrosis and ...
Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...
Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the best healthcare penny stocks to buy according to hedge funds.
Fibroblasts are an essential component of the heart, as they play key roles in its structure, development and response to ...
Heavy ETF outflows after news Cyprus to sell gold reserves* European shares, euro edge higher* Coming Up: U.S. weekly jobless claims; 1230 GMT(Updates throughout, changes dateline from SINGAPORE)By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results